About Matthew Kaeberlein
Matthew Kaeberlein co-founded Ora Biomedical and chairs its board. Ora screens compounds in whole living organisms for lifespan effects, then tests top results in human cells and skin. He founded and leads the nonprofit Dog Aging Institute. He is a general partner at Vivace Partners and chief science officer at DOS, or Dog Operating System. He co-founded the Dog Aging Project in 2014. The project studies pet dogs through long-term observation and placebo-controlled trials. He also co-founded Optispan, a health technology company for proactive care. He hosts the Longevity Science and Longevity for Dogs podcasts.
Kaeberlein formerly taught at the University of Washington School of Medicine. There, he founded the Healthy Aging and Longevity Research Institute and a healthy-aging training program. He has published more than 250 scientific papers. His honors include the Robert W. Kleemeier Award and the Nathan W. Shock Award. He serves on The Cat Health Company's scientific advisory board. The company develops longevity medicines for cats. He chairs the Montana Experimental Treatment Review Board.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Matthew Kaeberlein in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthew Kaeberlein works with at each company, as listed on that company's latest Form D.
